Camp4 Therapeutics Corp — Form D/A
Camp4 Therapeutics Corp of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2021-10-29. $45.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-29
- Form: D/A
- Accession: 0001736730-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $45.0M
- Investors: 7
- Date of first sale: 2021-03-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-392937
Issuer
- Name: Camp4 Therapeutics Corp
- CIK: 0001736730
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-651-8867
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Shaan Gandhi | Director | CAMBRIDGE, MA |
| ANDY SCHWAB | Director | CAMBRIDGE, MA |
| RAVI THADHANI | Director | CAMBRIDGE, MA |
| Andrew J Schwab | Director | San Francisco, CA |
| MICHAEL HIGGINS | Director | FRAMINGHAM, MA |
| Paula Ragan | Director | Boston, MA |
| STEVE HOLTZMAN | Director | CAMBRIDGE, MA |
| RAVI I THADHANI | Director | CAMBRIDGE, MA |
| RICHARD YOUNG | Director | CAMBRIDGE, MA |
| AMIR NASHAT | Director | San Diego, CA |
| CALEB MOORE | Executive Officer | CAMBRIDGE, MA |
| JORGE CONDE | Director | CAMBRIDGE, MA |
| JOSH MANDEL-BREHM | Director | CAMBRIDGE, MA |
| JOSH MANDEL-BREHM | Executive Officer | CAMBRIDGE, MA |
| ANN BARBIER | Executive Officer | CAMBRIDGE, MA |
| ALFICA SEHGAL | Executive Officer | CAMBRIDGE, MA |
| MICHELLE GATES | Executive Officer | CAMBRIDGE, MA |
| KELLY GOLD | Executive Officer | CAMBRIDGE, MA |
| DAVID BUMCROT | Executive Officer | CAMBRIDGE, MA |
| JAMES J BOYLAN | Director | CAMBRIDGE, MA |
| Shaan I Gandhi | Director | Natick, MA |
Other filings by this issuer (3)
More